STAT+: After death in gene therapy trial for a brain disease, progress is reported
Researchers on Friday presented detailed investigations into a gene therapy death that sparked fear and uncertainty last year among scientists who felt they had been approaching powerful treatments for a long list of brain diseases.
- “I think it can be tested, and I think this specific novel risk is one that we can try to mitigate and predict in the future.” Continue to STAT+ to read the full story….
The researchers did not conclude precisely what led to the patient’s death but proposed experiments to screen future therapies.
“What I want everyone to take home is: I think we’re starting to build a framework for testing this,” said Nicholas Flytzanis, chief research and innovation officer at Capsida Biotherapeutics.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →